These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 7998823)
21. Effects of cortical ablation on apomorphine- and scopolamine-induced changes in dopamine turnover and ascorbic acid catabolism in the rat striatum. Desole MS; Miele M; Enrico P; Esposito G; Fresu L; De Natale G; Miele E Eur J Pharmacol; 1992 Aug; 219(1):67-74. PubMed ID: 1356809 [TBL] [Abstract][Full Text] [Related]
22. On the mechanism of d-amphetamine-induced changes in glutamate, ascorbic acid and uric acid release in the striatum of freely moving rats. Miele M; Mura MA; Enrico P; Esposito G; Serra PA; Migheli R; Zangani D; Miele E; Desole MS Br J Pharmacol; 2000 Feb; 129(3):582-8. PubMed ID: 10711358 [TBL] [Abstract][Full Text] [Related]
23. Glutamate and catabolites of high-energy phosphates in the striatum and brainstem of young and aged rats subchronically exposed to manganese. Miele M; Serra PA; Esposito G; Delogu MR; Migheli R; Rocchitta G; Desole MS Aging (Milano); 2000 Oct; 12(5):393-7. PubMed ID: 11126527 [TBL] [Abstract][Full Text] [Related]
24. Glutathione deficiency potentiates manganese-induced increases in compounds associated with high-energy phosphate degradation in discrete brain areas of young and aged rats. Desole MS; Serra PA; Esposito G; Delogu MR; Migheli R; Fresu L; Rocchitta G; Miele M Aging (Milano); 2000 Dec; 12(6):470-7. PubMed ID: 11211958 [TBL] [Abstract][Full Text] [Related]
25. Effects of sufentanil on the release and metabolism of dopamine and ascorbic acid and glutamate release in the striatum of freely moving rats. Serra PA; Susini G; Rocchitta G; Migheli R; Dessanti G; Miele E; Desole MS; Miele M Neurosci Lett; 2003 Jun; 344(1):9-12. PubMed ID: 12781909 [TBL] [Abstract][Full Text] [Related]
27. Lipid peroxidation products inhibit dopamine catabolism yielding aberrant levels of a reactive intermediate. Rees JN; Florang VR; Anderson DG; Doorn JA Chem Res Toxicol; 2007 Oct; 20(10):1536-42. PubMed ID: 17887726 [TBL] [Abstract][Full Text] [Related]
28. Inhibitory effects of ascorbic acid on dopamine uptake by rat striatal synaptosomes: relationship to lipid peroxidation and oxidation of protein sulfhydryl groups. Morel P; Fauconneau B; Page G; Mirbeau T; Huguet F Neurosci Res; 1998 Oct; 32(2):171-9. PubMed ID: 9858024 [TBL] [Abstract][Full Text] [Related]
29. Analysis of the mechanism of d-amphetamine-and apomorphine-induced changes of ascorbic acid catabolism in discrete brain areas of the rat. Desole MS; Miele M; Esposito G; Enrico P; De Natale G; Miele E Pharmacol Res; 1991 Apr; 23(3):295-306. PubMed ID: 2068053 [TBL] [Abstract][Full Text] [Related]
30. Prooxidant properties of ascorbic acid in the nigrostriatal dopaminergic system of C57BL/6 mice. Kang MJ; Lee SS; Koh HC Toxicology; 2012 Mar; 294(1):1-8. PubMed ID: 22285708 [TBL] [Abstract][Full Text] [Related]
31. Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake. Teng L; Crooks PA; Sonsalla PK; Dwoskin LP J Pharmacol Exp Ther; 1997 Mar; 280(3):1432-44. PubMed ID: 9067333 [TBL] [Abstract][Full Text] [Related]
32. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis. Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456 [TBL] [Abstract][Full Text] [Related]
33. Methylmercury inhibits dopaminergic function in rat pup synaptosomes in an age-dependent manner. Dreiem A; Shan M; Okoniewski RJ; Sanchez-Morrissey S; Seegal RF Neurotoxicol Teratol; 2009; 31(5):312-7. PubMed ID: 19464365 [TBL] [Abstract][Full Text] [Related]
34. Restorative potential of dopaminergic grafts in presence of antioxidants in rat model of Parkinson's disease. Agrawal AK; Chaturvedi RK; Shukla S; Seth K; Chauhan S; Ahmad A; Seth PK J Chem Neuroanat; 2004 Dec; 28(4):253-64. PubMed ID: 15531136 [TBL] [Abstract][Full Text] [Related]
37. Enhancement of [3H]dopamine release and its [3H]metabolites in rat striatum by nicotinic drugs. Sakurai Y; Takano Y; Kohjimoto Y; Honda K; Kamiya HO Brain Res; 1982 Jun; 242(1):99-106. PubMed ID: 6179571 [TBL] [Abstract][Full Text] [Related]
38. A study on the role of nitric oxide and iron in 3-morpholino-sydnonimine-induced increases in dopamine release in the striatum of freely moving rats. Serra PA; Rocchitta G; Esposito G; Delogu MR; Migheli R; Miele E; Desole MS; Miele M Br J Pharmacol; 2001 Sep; 134(2):275-82. PubMed ID: 11564645 [TBL] [Abstract][Full Text] [Related]
39. Selective vulnerability of glutathione metabolism and cellular defense mechanisms in rat striatum to manganese. Liccione JJ; Maines MD J Pharmacol Exp Ther; 1988 Oct; 247(1):156-61. PubMed ID: 2902211 [TBL] [Abstract][Full Text] [Related]
40. Striatal and urinary DOPAC/DA ratio may indicate a long-lasting DA release enhancement by MPP+ and MPTP. Bagchi SP Neurochem Res; 1998 Feb; 23(2):127-34. PubMed ID: 9475505 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]